Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
557
datasets available to search
ShareScore release 0.9.0
Dataset results
557 results for “imatinib”
Imatinib Standard Dose (400 mg/Day) Versus Imatinib High Dose (800 mg/Day)
ClinicalTrials.gov study NCT00514488. IPD Sharing: Not stated. Countries: 1. Publications: 7.
Imatinib Mesylate and Temozolomide in Treating Patients With Malignant Glioma
ClinicalTrials.gov study NCT00354068. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Docetaxel With or Without Imatinib Mesylate in Treating Patients With Androgen-Independent Prostate Cancer and Bone Metastases
ClinicalTrials.gov study NCT00080678. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Ipilimumab and Imatinib Mesylate in Advanced Cancer
ClinicalTrials.gov study NCT01738139. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Imatinib Mesylate in Treating Patients With Recurrent or Refractory Fibromatosis
ClinicalTrials.gov study NCT00287846. IPD Sharing: NO. Countries: 1. Publications: 1.
SSG XXV: The Stop-GIST Trial; Discontinuation of Imatinib in Patients With Oligo-metastatic GIST
ClinicalTrials.gov study NCT02924714. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Imatinib Mesylate in Treating Patients With Refractory or Relapsed Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer, or Ovarian Low Malignant Potential Tumor
ClinicalTrials.gov study NCT00039585. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Retrospective Pharmacokinetics and Pharmacogenomics Research of Imatinib in Gastrointestinal Stromal Tumor Treatment
ClinicalTrials.gov study NCT03092128. IPD Sharing: NO. Countries: 1. Publications: 4.
Imatinib Mesylate in Combination With Docetaxel for Advanced, Platinum-Refractory Ovarian Cancer
ClinicalTrials.gov study NCT00216112. IPD Sharing: NO. Countries: 1. Publications: 1.
Improving Treatment Outcomes in Chronic Myeloid Leukaemia Patients Using Imatinib and Artesunate Combination Therapy
ClinicalTrials.gov study NCT07022743. IPD Sharing: NO. Countries: 1. Publications: 8.
Safety and Efficacy of Imatinib Added to Chemotherapy in Treatment of Ph+ Acute Lymphoblastic Leukemia in Children
ClinicalTrials.gov study NCT00287105. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Efficiency of Imatinib Treatment Maintenance or Interruption After 3 Years of Adjuvant Treatment in Patients With Gastrointestinal Stromal Tumours (GIST)
ClinicalTrials.gov study NCT02260505. IPD Sharing: Not stated. Countries: 1. Publications: 24.
Study Comparing 12 Months Versus 36 Months of Imatinib in the Treatment of Gastrointestinal Stromal Tumor (GIST)
ClinicalTrials.gov study NCT00116935. IPD Sharing: Not stated. Countries: 1. Publications: 5.
Imatinib Mesylate in Treating Patients With Primary Gastrointestinal Stromal Tumor That Has Been Completely Removed By Surgery
ClinicalTrials.gov study NCT00041197. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Proof of Concept Trial of Gleevec (Imatinib) in Active Diffuse Scleroderma
ClinicalTrials.gov study NCT01545427. IPD Sharing: Not stated. Countries: 1. Publications: 10.
Glivec® (Imatinib Mesylate, STI571) in Monotherapy Versus Glivec®-Interferon Alpha in the Treatment of Chronic-Phase Chronic Myeloid Leukaemia
ClinicalTrials.gov study NCT00390897. IPD Sharing: Not stated. Countries: 1. Publications: 17.
Imatinib Mesylate in Treating Patients With Recurrent Malignant Glioma or Meningioma
ClinicalTrials.gov study NCT00010049. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Everolimus in Combination With Imatinib in Patients With Glivec Refractory/Resistant Gastrointestinal Stromal Tumors
ClinicalTrials.gov study NCT01275222. IPD Sharing: YES. Countries: 4. Publications: 0.
Imatinib Mesylate in Treating Patients With Locally Advanced or Metastatic Dermatofibrosarcoma Protuberans or Giant Cell Fibroblastoma
ClinicalTrials.gov study NCT00085475. IPD Sharing: Not stated. Countries: 4. Publications: 1.
Cladribine, Cytarabine, and Imatinib Mesylate in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia or Blastic Phase Chronic Myelogenous Leukemia
ClinicalTrials.gov study NCT00258271. IPD Sharing: Not stated. Countries: 1. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.